Christine Ko, MD, is professor of dermatology and pathology at Yale University and a presenter of “What's New in Dermatopathology” at this year’s American Academy of Dermatology Virtual Meeting Experience (AAD VMX).
Christine Ko, MD, professor of dermatology and pathology at Yale University and a presenter of “What's New in Dermatopathology,” speaks on COVID-19 skin-related vaccine reactions and clinical-pathologic discussions to come at this year’s American Academy of Dermatology Virtual Meeting Experience.
Transcript
With the cancellation of last year's meeting, what are you looking forward to hearing about this year?
I always love the AAD meeting, and it was a disappointment, I think for everyone, as the pandemic has sort of chugged along that we can’t go to the meetings that we love. So even though it's virtual again, this year, I'm excited to hear some of the types of sessions and the speakers that I love to listen to. A lot of what I love is clinical-pathologic correlation, so I'm excited to hear Dr. Callen’s session [Jeffrey P. Callen, MS, FACP, FAAD, MACR, University of Louisville School of Medicine]. And there's some other clinical-pathologic correlation sessions, for example, led by Dr. Samimi [Sara S. Samimi, MD, Penn Medicine].
Can you preview for us your presentation, “What’s New in Dermatopathology?”
We're going to try to have a somewhat interactive, visually rich presentation of dermoscopy. So, how to look at the clinical, look with that magnifier, the dermatoscope, and then also correlate it to what you would see under the microscope. I think that'll be really exciting and very visually interesting. That's going to be by Dr. Michelle Tarbox [Michelle Tarbox, MD, Texas Tech University Health Sciences Center], who's from Texas. And then one of my awesome colleagues, Dr. Bill Damsky [William Damsky, MD, PhD, Yale School of Medicine] is going to address COVID arm, which is, I think, a very timely thing as the vaccine continues to roll out across the nation and the world. And Dr. Nooshin Brinster [Nooshin K. Brinster, MD, NYU Langone] from NYU and Dr. Tarbox and myself, we'll have a little fun discussion with Dr. Damsky about vaccine reactions, what we've seen as pertains to the skin, and what other interesting things about the skin and COVID that people might want to talk about. So there'll be some Q&A from the audience if they want.
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Real-World Data Show Poor Outcomes Among Patients With ACS and Blood Cancers
December 8th 2023A real-world analysis found that patients with acute coronary syndrome who were also diagnosed with a hematologic malignancy had worse survival outcomes, and patients with multiple myeloma were overrepresented in the population.
Read More